Hair |
|
|
Clinical Trial: A Study To Evaluate The Effectiveness Of An Investigational Product In The Treatment Of Male Pattern Hair Loss
This study is no longer recruiting patients.
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Androgenetic Alopecia | Drug: Investigational product | Phase III |
MedlinePlus related topics: Hair Diseases and Hair Loss
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of an Investigational Product in the Treatment of Androgenetic Alopecia in Males
Expected Total Enrollment: 360
Study start: October 2003
Eligibility
Accepts Healthy Volunteers
Inclusion Criteria:
- Presence of androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale
Exclusion Criteria:
- Known sensitivity to the investigational product.
Location Information
Pfizer CT.gov Call Center, Study Director, Pfizer
More Information
Last Updated: September 12, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00151515
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Endocrinology and Hirsutism (Hormone Foundation)
- Excess Hair (American Academy of Family Physicians)

Not Signed In -

